Medicare Proposed and Final Rule Updates: FY 2026 IPPS Final Rule and CY 2026 OPPS and MPFS Proposed Rules

Join ASTCT Director of Government Relations, Molly Ford, and Reimbursement and Policy Advisors from Nimitt Consulting for a webinar on Medicare rule updates on August 20 at 12 p.m. CDT/1 p.m. EDT.

This webinar will cover:

• FY 2026 Inpatient Prospective Payment System (IPPS) Final Rule:
  • Final payment rates and policies for key MS-DRGs for Stem Cell Transplant MS-DRGs (014, 016 and 017) and CAR-T and Other Immunotherapies (MS-DRG 018)
  • Discussion of CMS’ final decisions on relevant New Technology Add-on Payments (NTAP) for cell and gene therapy products
  • Final fixed outlier loss threshold and market basket update amounts
• CY 2026 Outpatient Prospective Payment System (OPPS) Proposed Rule:
  • Major payment and policy proposals related to cell and gene therapies
  • Other major proposals likely to impact hospitals if finalized
• CY 2026 Medicare Physician Fee Schedule (MPFS) Proposed Rule:
  • Major payment and policy proposals related to cell and gene therapies
  • Other major proposals including new codes and payment rates applicable to ASTCT member physicians

There will be a Q&A section at the end of the webinar, so be sure to register and submit any questions in advance that you would like answered during the webinar to info@astct.org. If you are unable to join, the recording will be made available. 

Please consider sharing this webinar with your network of doctors, administrators, providers, or any other colleagues that may be interested.